Your browser doesn't support javascript.
loading
Differential promoter utilization by the c-myc gene in mitogen- and interleukin-2-stimulated human lymphocytes.
Broome, H E; Reed, J C; Godillot, E P; Hoover, R G.
Afiliação
  • Broome HE; Department of Pathology and Laboratory Medicine, School of Medicine, University of Pennsylvania, Philadelphia 19104-6082.
Mol Cell Biol ; 7(8): 2988-93, 1987 Aug.
Article em En | MEDLINE | ID: mdl-3118189
ABSTRACT
Transcription of the c-myc gene is initiated from two principal promoters, P1 and P2. We demonstrate here that a shift in promoter utilization occurred with time in human peripheral blood mononuclear cells (PBMC) that had been stimulated to proliferate. The P1/P2 ratio reached a maximum of approximately 1.3 at 4 h after phytohemagglutinin stimulation and a minimum of 0.31 at 48 h. Actinomycin decay experiments demonstrated that both P1 and P2 transcripts had similar half-lives at early and late times after mitogen stimulation, indicating that the shift in promoter utilization was probably not posttranscriptionally regulated. Addition of interleukin-2 to previously activated PBMC increased c-myc mRNA, but unlike increases after mitogen stimulation, the P1/P2 ratio stayed less than 0.5. Our findings demonstrated that there was a difference between mitogen- and interleukin-2-stimulated increases in c-myc RNA in PBMC.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proto-Oncogenes / Linfócitos / Receptores Imunológicos / Interleucina-2 / Regiões Promotoras Genéticas / Mitógenos Limite: Humans Idioma: En Revista: Mol Cell Biol Ano de publicação: 1987 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proto-Oncogenes / Linfócitos / Receptores Imunológicos / Interleucina-2 / Regiões Promotoras Genéticas / Mitógenos Limite: Humans Idioma: En Revista: Mol Cell Biol Ano de publicação: 1987 Tipo de documento: Article